Travere Therapeutics Inc (TVTX)
5.21
-0.24
(-4.40%)
USD |
NASDAQ |
Apr 25, 10:49
Travere Therapeutics Cash from Operations (TTM): -280.02M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -280.02M |
| September 30, 2023 | -264.19M |
| June 30, 2023 | -244.58M |
| March 31, 2023 | -212.09M |
| December 31, 2022 | -186.29M |
| September 30, 2022 | -158.53M |
| June 30, 2022 | -86.94M |
| March 31, 2022 | -43.64M |
| December 31, 2021 | -14.79M |
| September 30, 2021 | -1.785M |
| June 30, 2021 | -27.11M |
| March 31, 2021 | -40.06M |
| December 31, 2020 | -42.74M |
| September 30, 2020 | -33.36M |
| June 30, 2020 | -54.22M |
| March 31, 2020 | -66.88M |
| December 31, 2019 | -58.21M |
| September 30, 2019 | -57.29M |
| June 30, 2019 | -47.06M |
| March 31, 2019 | -30.72M |
| December 31, 2018 | -24.96M |
| September 30, 2018 | -22.25M |
| June 30, 2018 | -12.15M |
| March 31, 2018 | -3.924M |
| December 31, 2017 | 7.403M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.236M |
| June 30, 2017 | -1.805M |
| March 31, 2017 | -3.281M |
| December 31, 2016 | -3.441M |
| September 30, 2016 | 1.50M |
| June 30, 2016 | -2.39M |
| March 31, 2016 | 1.638M |
| December 31, 2015 | -1.389M |
| September 30, 2015 | -6.932M |
| June 30, 2015 | -23.17M |
| March 31, 2015 | -42.64M |
| December 31, 2014 | -45.85M |
| September 30, 2014 | -44.90M |
| June 30, 2014 | -32.06M |
| March 31, 2014 | -22.82M |
| December 31, 2013 | -17.59M |
| September 30, 2013 | -9.442M |
| June 30, 2013 | -6.787M |
| March 31, 2013 | -4.579M |
| November 30, 2012 | 0.00 |
| August 31, 2012 | 0.00 |
| May 31, 2012 | 0.00 |
| February 29, 2012 | 0.00 |
| November 30, 2011 | -0.0006M |
| August 31, 2011 | -0.0007M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-280.02M
Minimum
Dec 2023
-1.785M
Maximum
Sep 2021
-101.04M
Average
-57.29M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
| AtriCure Inc | 4.484M |
| Bio-Rad Laboratories Inc | 374.94M |
| Artivion Inc | 18.82M |
| Shockwave Medical Inc | 196.05M |
| Perspective Therapeutics Inc | -36.91M |